Coulter Partners announces top hires for VC & PE portfolio companies Q4-2023

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function Focus area Location

CEO	Reconstructive surgery	Italy
CEO	Medical devices	Israel
CEO	Immuno-oncology platform	US
Chief Scientific Officer	Gene therapies	UK
Chief Business Officer	Precision biotherapeutics	Singapore
Chief Product Officer	Medical information services	UK
SVP Global Strategic Business Development	Drug discovery services	Germany
VP Drug Discovery & Preclinical Development	CNS platform	UK
Head of Clinical Operations	Small molecule biopharma	Denmark
Country Director	Life sciences investor	US
Head of Alliance Management	Incubator	UK
Chair	Medical devices	Israel
Chair	Tech enabled care provider	US
US-based Board Director	T-cell therapies	France

Newly opened projects include:

Function Focus area Location

CEO	Small molecule biopharma	Australia
CEO	Synthetic biology technologies	US
CEO	Protein alternatives	US
Chief Financial Officer	Remote monitoring	France
Chief Operating Officer	Contract research services	Germany
Chief Scientific Officer	Gene therapies	US
Chief of Staff	Vaccines	Denmark
Chief Business Officer	Immuno-oncology platform	UK
Head of Tech Ops & Manufacturing, UK	Contract manufacturing services	US
VP BD Cell Therapy	Precision medicines	UK
VP Regulatory Affairs & Quality Assurance, Europe	Surgical devices	US
Director Market Access & Pricing Europe	Ophthalmology therapeutics	Italy
Marketing & Communications Director	AI for drug design	France